LINDA ADAMS: Open Payments
NPI 1578907101 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,790 in 50 payments from 9 companies in 2025. Trend: 2023 $1,337 · 2024 $1,224 · 2025 $3,790
Food & beverage: $3,567Education: $223
| Company | Payments | Amount |
|---|---|---|
| Alpha Cognition USA, Inc. | 17 | $1,850 |
| Teva Pharmaceuticals USA, Inc. | 10 | $746 |
| Janssen Pharmaceuticals, Inc | 4 | $336 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $244 |
| Otsuka America Pharmaceutical, Inc. | 6 | $209 |
| Neurocrine BioSciences, Inc. | 2 | $157 |
| ABBVIE INC. | 1 | $119 |
| Lundbeck LLC | 5 | $97 |
| HARMONY BIOSCIENCES LLC | 2 | $32 |
Products named: Zunveyl, AUSTEDO XR, REXULTI, INVEGA SUSTENNA, CAPLYTA, INGREZZA, VRAYLAR, UZEDY.
Industry payments across OK — which companies pay providers there.
